Company Overview of VaxInnate Corporation
VaxInnate Corporation, a biotechnology company, provides a technology that involves genetically fusing vaccine antigens to the bacterial protein flagellin, a potent stimulator of the innate immune system. The company’s technology platform is based on proprietary toll-like receptor technology, which potentiates the immune response. Its vaccines focus on infectious diseases, including seasonal and pandemic influenza, clostridium difficile, and dengue. VaxInnate Corporation was incorporated in 2001 and is headquartered in Cranbury, New Jersey.
3 Cedar Brook Drive
Cranbury, NJ 08512
Founded in 2001
Key Executives for VaxInnate Corporation
Chief Executive Officer, President and Director
Vice President of Business Development
Compensation as of Fiscal Year 2015.
VaxInnate Corporation Key Developments
VaxInnate, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 10:45 AM
Jun 18 15
VaxInnate, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 10:45 AM. Venue: Le Parker Meridien Hotel, 119 W. 56th Street, New York, NY 10019, United States. Speakers: Wayne F. Pisano, Chief Executive Officer, President and Director.
VaxInnate Corporation Appoints Thomas P. Monath to Board of Directors
Jun 17 15
VaxInnate Corporation announced the appointment of Thomas P. Monath, MD to the Company's board of directors. Dr. Monath is an internationally known virologist and vaccinologist with significant experience in the biotechnology industry and at the Centers for Disease Control and Prevention (CDC). Dr. Monath currently serves as the chief scientific and chief operating officer of BioProtection Systems, a subsidiary of NewLink Genetics Corporation, where he is leading the development of an Ebola virus vaccine in partnership with Merck. Prior to joining NewLink, Tom held various industry roles at PaxVax Inc., Hookipa Biotech AG, Juvaris Inc., Xcellerex Inc. and Acambis Inc. prior to its acquisition by Sanofi Pasteur. In these roles, he was involved in the development of a broad array of vaccines including those for cholera, influenza, polio, malaria, HIV, anthrax, dengue, Japanese encephalitis, West Nile, yellow fever, Clostridium difficile and smallpox.
VaxInnate, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-15-2015 10:00 AM
Mar 25 15
VaxInnate, Inc. Presents at Needham & Company's 14th Annual Healthcare Conference, Apr-15-2015 10:00 AM. Venue: Westin Grand Central Hotel, New York, New York, United States. Speakers: Wayne F. Pisano, Chief Executive Officer, President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
September 18, 2015